Pancreatic Cancer Organoids for Determining Sensitivity to Bromodomain and Extra-Terminal Inhibitors (BETi)

Pancreatic ductal adenocarcinoma (PDAC) is a heterogeneous disease, therefore stratification of patients is essential to predict their responses to therapies and to choose the best treatment. PDAC-derived organoids were produced from PDTX and Endoscopic Ultrasound-Guided Fine-Needle Aspiration (EUS-...

Descripción completa

Detalles Bibliográficos
Autores principales: Bian, Benjamin, Juiz, Natalia Anahi, Gayet, Odile, Bigonnet, Martin, Brandone, Nicolas, Roques, Julie, Cros, Jérôme, Wang, Nenghui, Dusetti, Nelson, Iovanna, Juan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2019
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6560163/
https://www.ncbi.nlm.nih.gov/pubmed/31231611
http://dx.doi.org/10.3389/fonc.2019.00475

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6560163/
https://www.ncbi.nlm.nih.gov/pubmed/31231611
http://dx.doi.org/10.3389/fonc.2019.00475

Ejemplares similares